By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Octapharma USA, Inc. 

13800 Coppermine Road

Herndon  Virginia  20170  U.S.A.
Phone: 703-234-5375 Fax:



Company News
Octapharma USA Announces Two Hemophilia A Clinical Trials To Utilize WILATE 11/14/2016 11:29:49 AM
Octapharma USA Announces U.S. Availability Of NUWIQ To Treat Adults And Children With Hemophilia A 1/4/2016 10:31:05 AM
FDA Green Lights Octapharma USA's NUWIQ for Hemophilia A 9/15/2015 10:27:04 AM
Octapharma USA, Inc.: FDA Approves WILATE License Supplement – Perioperative Management Of Bleeding In Patients With Von Willebrand Disease 8/13/2015 10:19:37 AM
Octapharma USA, Inc.: FDA Approves Octaplas License Supplement, Increasing Post Thaw Permitted Storage Time 3/9/2015 10:27:43 AM
Octapharma USA, Inc. Launches Co-Pay Assistance Program For Patients Receiving Wilate® 2/2/2015 10:51:58 AM
Octapharma USA, Inc. Announces FDA Approval For 2nd Octagam® 10% Manufacturing Site, Expanding Product Availability 1/26/2015 8:40:02 AM
Octapharma USA, Inc. Announces FDA Approval Of Octagam 10%, Expanding Its Immune Globulin Therapy Portfolio 7/15/2014 9:09:24 AM
Octapharma USA, Inc. Supports Victory for Women Program, Presents Coagulation Research at 65th Annual NHF Meeting 10/1/2013 9:52:30 AM
Octapharma USA, Inc. Announces Octaplas™ Now Available for U.S. Patients 8/29/2013 9:59:57 AM